dc.contributor.author |
Christodoulou C |
|
dc.contributor.author |
Papadopoulou A |
|
dc.contributor.author |
Rizos E |
|
dc.contributor.author |
Tournikioti K |
|
dc.contributor.author |
Gonda Xénia |
|
dc.contributor.author |
Douzenis A |
|
dc.contributor.author |
Lykouras L |
|
dc.date.accessioned |
2014-12-12T08:25:36Z |
|
dc.date.available |
2014-12-12T08:25:36Z |
|
dc.date.issued |
2010 |
|
dc.identifier |
76749091920 |
|
dc.identifier.citation |
pagination=5;
journalVolume=9;
journalTitle=ANNALS OF GENERAL PSYCHIATRY; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/763 |
|
dc.identifier.uri |
doi:10.1186/1744-859X-9-5 |
|
dc.description.abstract |
Background: We present the case of a 52-year-old woman with depression who developed extrapyramidal symptoms (mainly parkinsonism) and suicidal ideation while on fluoxetine.Methods: The patient underwent neurological and neuroimaging examination.Results: The patient's neurological and neuroimaging examinations were normal and there was no other cause of extrapyramidal symptoms. The patient showed remission of the aforementioned symptomatology when fluoxetine was discontinued.Conclusions: This case shows that fluoxetine can be associated with extrapyramidal symptoms, and this may have an aggravating affect on clinical depression progress and the emergence of suicidal ideation. © 2010 Christodoulou et al; licensee BioMed Central Ltd. |
|
dc.relation.ispartof |
urn:issn:1744-859X |
|
dc.title |
Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: A case report |
|
dc.type |
Journal Article |
|
dc.date.updated |
2014-12-11T13:48:08Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
1801040 |
|
dc.identifier.wos |
000208606200005 |
|
dc.identifier.pubmed |
20148108 |
|
dc.contributor.department |
SE/ÁOK/K/Kútvölgyi Klinikai Tömb egyéb osztályok |
|
dc.contributor.institution |
Semmelweis Egyetem |
|